Evolent Health Inc (EVH)
23.00
+0.10
(+0.44%)
USD |
NYSE |
May 21, 15:04
Evolent Health Shareholders Equity (Quarterly): 1.048B for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.048B |
| December 31, 2023 | 1.068B |
| September 30, 2023 | 1.096B |
| June 30, 2023 | 1.093B |
| March 31, 2023 | 1.292B |
| December 31, 2022 | 859.42M |
| September 30, 2022 | 856.14M |
| June 30, 2022 | 613.09M |
| March 31, 2022 | 611.21M |
| December 31, 2021 | 693.63M |
| September 30, 2021 | 607.48M |
| June 30, 2021 | 614.19M |
| March 31, 2021 | 617.30M |
| December 31, 2020 | 619.60M |
| September 30, 2020 | 629.82M |
| June 30, 2020 | 646.86M |
| March 31, 2020 | 847.07M |
| December 31, 2019 | 922.36M |
| September 30, 2019 | 1.108B |
| Date | Value |
|---|---|
| June 30, 2019 | 1.131B |
| March 31, 2019 | 1.100B |
| December 31, 2018 | 1.144B |
| September 30, 2018 | 1.039B |
| June 30, 2018 | 1.041B |
| March 31, 2018 | 1.043B |
| December 31, 2017 | 1.011B |
| September 30, 2017 | 1.020B |
| June 30, 2017 | 859.77M |
| March 31, 2017 | 750.47M |
| December 31, 2016 | 702.53M |
| September 30, 2016 | 562.23M |
| June 30, 2016 | 537.73M |
| March 31, 2016 | 541.52M |
| December 31, 2015 | 649.34M |
| September 30, 2015 | 646.67M |
| June 30, 2015 | 654.21M |
| March 31, 2015 | 7.714M |
| December 31, 2014 | -2.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
607.48M
Minimum
Sep 2021
1.292B
Maximum
Mar 2023
848.73M
Average
851.60M
Median
Shareholders Equity (Quarterly) Benchmarks
| American Shared Hospital Services | 22.84M |
| Novo Integrated Sciences Inc | 22.19M |
| Astrana Health Inc | 653.49M |
| Cryo-Cell International Inc | -10.34M |
| P3 Health Partners Inc | 146.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.644B |
| Total Liabilities (Quarterly) | 1.596B |
| Debt to Equity Ratio | 0.5706 |
| Current Ratio | 1.016 |
| Net Debt Paydown Yield | -0.98% |